First Financial Equity Corporation’s Bristol-Myers Squibb BMY Stock Holding History

First Financial Equity Corporation’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$591K	Buy	+10,673	New	+$585K	0.1%	196

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Financial Equity Corporation's BMY Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Bristol-Myers Squibb (BMY) in Q1 2017: 10,673 shares worth $591K. The stake represents 0.1% of the portfolio and ranks #196 among its holdings.

1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

First Financial Equity Corporation held 10,673 shares of Bristol-Myers Squibb worth $591K as of Q1 2017.
Bristol-Myers Squibb was a new First Financial Equity Corporation position in Q1 2017.
Bristol-Myers Squibb made up 0.1% of First Financial Equity Corporation's portfolio in Q1 2017, its #196 holding.
1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.